-
Ongoing_mutagenesis_RNAseq
Study
EGAS00001002364
-
The molecular landscape of colorectal cancer (5 cases)
Study
EGAS00001002374
-
Field_effect_of_healthy_and_diseased_livers
Study
EGAS00001002382
-
Whole Genome Sequencing of Liver Cancers
Study
EGAS00001002408
-
Whole Mitochondrial Sequencing of Gingivo-buccal Cancer: ICGC-India Project
Study
EGAS00001002425
-
Successful immune checkpoint blockade in a patient with advanced stage microsatellite unstable biliary tract cancer (H021)
Study
EGAS00001002441
-
Genetic Risk for Subsequent Neoplasms among Long-term Survivors of Childhood Cancer in the St. Jude Lifetime Cohort
Study
EGAS00001002499
-
Y_chromosome_mis_segregation_in_the_DLD_1_cell_line
Study
EGAS00001002551
-
Combination Therapies for Personalised Cancer Medicine in 11-18
Study
EGAS00001002579
-
Whole Genomes Define Concordance in Matched Primary, Xenograft, and Organoid Models of Pancreas Cancer
Study
EGAS00001002597
-
Somatic_Variation_Angiosarcoma
Study
EGAS00001002610
-
Somatic_mutation_and_clonal_evolution_in_the_human_bladder_TGS
Study
EGAS00001002659
-
Employing_single_cell_sequencing_for_detection_of_mutational_signatures_reflecting_on_going_mutagenesis_
Study
EGAS00001002679
-
The identification of genetic vulnerabilities in head and neck cancers for the development of novel treatments.
Study
EGAS00001002682
-
Characterization of genetic intratumor heterogeneity in colorectal cancer and matching patient-derived spheroid cultures.
Study
EGAS00001002684
-
Defining the metastasome in colorectal cancer: Implications for hypotheses on metastasis evolution and personalized therapy (HIPO-032)
Study
EGAS00001002717
-
Keratinocyte_CRISPR_screens
Study
EGAS00001002714
-
Mitochondrial-Nuclear Mutational Cross-Talk Drives Recurrence of Localized Prostate Cancer
Study
EGAS00001001782
-
Spiradenocarcinoma
Study
EGAS00001001799
-
In this study, we performed exon sequencing (WXS) of 80 paired Brain cancer tumors and adjacent normal tissues to identify novel potential biomarkers. We extracted mutational signatures which induce somatic mutations . Our study covers a comprehensive genetic framework that can be used in clinical trials and treatment modalities in Brain cancer.
Study
EGAS00001002352
-
2017_AML_WGS
Study
EGAS00001002388
-
RRBS sequencing of 7 tumour regions and a normal sample from a single TRACERx patient.
Study
EGAS00001002484
-
H3K27ac ChIP-seq in TMPRSS2:ERG positive and negative prostate cancer tissue samples
Study
EGAS00001002496
-
Combination Therapies for Personalised Cancer Medicine in drug resistant EGFR mutant lung cancer
Study
EGAS00001002509
-
Comparative genomics research for Chinese colorectal cancer
Study
EGAS00001002607